Medunik Canada is dedicated to providing Canadians suffering from rare diseases with access to orphan drugs that are not currently available in Canada. We make these treatment options available by building strategic partnerships with international companies to bring their products to the Canadian market. Through in-licensing partnerships, Medunik Canada offers turn-key operations and provides medical scientific liaisons, approval and market access processes and marketing for orphan disease treatments.